Journal Title
Annals of Internal Medicine
Volume Number
172
Issue Number
10
Collection name
Faculty Scholarship
Creator
Fink, H.A.
Linskens, Eric J.
MacDonald, R.
Silverman, Pombie C.
McCarten, J. Riley
Talley, Kristine M.C.
Forte, Mary L.
Desai, Priyanka J.
Nelson, Victoria A.
Miller, Margaret A.
Hemmy, Laura S.
Brasure, M.
Taylor, B.C.
Ng, Weiwen
Ouellette, Jeannine M.
Sheets, Kerry M.
Wilt, Timothy J.
Butler, M.
Creator Affiliated Organization
Northwestern Health Sciences University
Description
The article was co-authored by Northwestern Health Sciences University researcher Mary L. Forte. The article was published in Annals of Internal Medicine and was published in 2020.
Abstract

Purpose:  To summarize evidence on the effects of prescription drugs and supplements for CATD treatment.

Conclusion:  Cholinesterase inhibitors and memantine slightly reduced short-term cognitive decline, and cholinesterase inhibitors slightly reduced reported functional decline, but differences versus placebo were of uncertain clinical importance. Evidence was mostly insufficient on drug treatment of BPSD and on supplements for all outcomes.

 

Publisher
American College of Physicians
Date Published
2020
Local Subject
Faculty scholarship
Alzheimer Disease
Prescription Drugs
Dietary Supplements
Resource Type
Text
File Type
application/pdf
Genre
Article
Copyright Date
2020
Contact Information
Northwestern Health Sciences University, 2501 West 84th Street, Bloomington, MN 55431. https://www.nwhealth.edu/library/
Copyright
In Copyright
Rights Holder
American College of Physicians